 |  |  |  |  |  |  |  |
SEARCH:
Sponsored by:
|
Genitourinary
|
|
|
The Food and Drug Administration has tracked counterfeit bevacizumab, the cancer drug marketed as Avastin, to at least one foreign supplier and identified 19 medical practices in the United States that purchased unapproved cancer medicines, possibly including counterfeit bevacizumab. The FDA said... »
Featured Article
Prostate Cancer More Likely to Recur, Kill Men Who Smoke at Diagnosis
Men who smoke at the time of prostate cancer diagnosis have substantially increased rates of overall mortality and prostate cancer mortality and biochemical recurrence compared with men who had never smoked, according to a... »
Men who smoke at the time of prostate cancer diagnosis have substantially increased rates of overall mortality and prostate cancer mortality and biochemical recurrence compared with men who had never smoked, according to a... »
Commentaries
ASTRO 2011 and the Future of Radiation Oncology
Dr. Anthony Zietman discusses how highlights of the ASTRO 2011 annual meeting bode well for men with prostate cancer. He also addresses the future of radiation oncology in an era of molecular targeting. »
What Matters: Active Surveillance a Conundrum in Young, Low-Risk Men
BY JUDD W. MOUL, M.D. The National Comprehensive Cancer Center guidelines are extremely useful for clinicians practicing cancer care. While the guidelines offer great advice and update the literature on various patterns of... »
Dr. Anthony Zietman discusses how highlights of the ASTRO 2011 annual meeting bode well for men with prostate cancer. He also addresses the future of radiation oncology in an era of molecular targeting. »
What Matters: Active Surveillance a Conundrum in Young, Low-Risk Men
BY JUDD W. MOUL, M.D. The National Comprehensive Cancer Center guidelines are extremely useful for clinicians practicing cancer care. While the guidelines offer great advice and update the literature on various patterns of... »
News
FDA Tracks Fake Avastin to Foreign Supply Distributed in U.S.
The Food and Drug Administration has tracked counterfeit bevacizumab, the cancer drug marketed as Avastin, to at least one foreign supplier and identified 19 medical practices in the United States that purchased unapproved... »
Vitamin E Supplements Linked to Increase in Prostate Cancer Risk
SAN FRANCISCO – Healthy middle-aged and older men who take vitamin E supplements have an increased risk of prostate cancer, although the risk takes some time to emerge, suggests an update of the randomized SELECT prevention... »
Costs Don't Always Match Outcomes of Prostate Cancer Treatments
SAN FRANCISCO – Two new U.S. studies involving more than 150,000 older men with prostate cancer are likely to add to the intense debate about the optimal treatment for early disease, especially the various radiation therapy... »
The Food and Drug Administration has tracked counterfeit bevacizumab, the cancer drug marketed as Avastin, to at least one foreign supplier and identified 19 medical practices in the United States that purchased unapproved... »
Vitamin E Supplements Linked to Increase in Prostate Cancer Risk
SAN FRANCISCO – Healthy middle-aged and older men who take vitamin E supplements have an increased risk of prostate cancer, although the risk takes some time to emerge, suggests an update of the randomized SELECT prevention... »
Costs Don't Always Match Outcomes of Prostate Cancer Treatments
SAN FRANCISCO – Two new U.S. studies involving more than 150,000 older men with prostate cancer are likely to add to the intense debate about the optimal treatment for early disease, especially the various radiation therapy... »
Video
ASTRO 2011 and the Future of Radiation Oncology
Dr. Anthony Zietman discusses how highlights of the ASTRO 2011 annual meeting bode well for men with prostate cancer. He also addresses the future of radiation oncology in an era of molecular targeting. »
Prostate Cancer More Likely to Recur, Kill Men Who Smoke at Diagnosis
Men who smoke at the time of prostate cancer diagnosis have substantially increased rates of overall mortality and prostate cancer mortality and biochemical recurrence compared with men who had never smoked, according to a... »
Video Report: What's the Future of Prostate Cancer Care?
Dr. Walter Stadler of the University of Chicago speaks about the changing landscape of prostate cancer care for physicians and patients. Newer modalities mean growing complexities in treating prostate disease. »
Dr. Anthony Zietman discusses how highlights of the ASTRO 2011 annual meeting bode well for men with prostate cancer. He also addresses the future of radiation oncology in an era of molecular targeting. »
Prostate Cancer More Likely to Recur, Kill Men Who Smoke at Diagnosis
Men who smoke at the time of prostate cancer diagnosis have substantially increased rates of overall mortality and prostate cancer mortality and biochemical recurrence compared with men who had never smoked, according to a... »
Video Report: What's the Future of Prostate Cancer Care?
Dr. Walter Stadler of the University of Chicago speaks about the changing landscape of prostate cancer care for physicians and patients. Newer modalities mean growing complexities in treating prostate disease. »
Current Issue
The Oncology Report
Comprehensive reports and expert commentary
on the latest advances in cancer treatment from
the world's major oncology meetings.
Past issues, click here »
calendar
More Calendar »